Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GenSci048 in Active Non-infectious Uveitis
NCT07547995Phase 2Recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of genakumab in uveitis, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jun 2026; status: recruiting.
02
Drugs
genakumab
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT07547995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07547995.